Indo Us Bio-Tech Fair Value
Indo Us Bio-Tech fair value. Indo Us Bio-Tech (INDOUS) average fair value is ₹70.31 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹75.53 (-6.92%), fair value range ₹43.33–₹97.28. Explore INDOUS true value to estimate fundamental worth using multiple valuation models.
Fair Value Analysis Export
INDOUS Fair Value vs Current Price — Valuation Summary
INDOUS average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. For live price and a broader fundamental view, visit Indo Us Bio-Tech share price today.
P/B Based Valuation
Asset-Based Valuation
INDOUS Fair Value Analysis — Data Sources & Coverage
Indo Us Bio-Tech financial data sources, valuation methods applied and sector benchmarks used. Check INDOUS market value to track the company's total market size over time.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
INDOUS vs FMCG Sector Peers — P/E, P/B & Market Cap
Indo Us Bio-Tech P/E ratio, P/B ratio and market capitalisation vs FMCG sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Shreeji Global FMCG | SHETHJI | - | 3.23 | ₹423 |
| Swasth Foodtech | SWASTH | -7.45 | 0.5 | ₹10 |
| Patanjali Foods | PATANJALI | 20.06 | 3.02 | ₹38,644 |
| Kwality Walls | KWIL | -28.73 | 14.36 | ₹9,431 |
| Prime Fresh | PRIMEFRESH | 13.95 | 2.44 | ₹211 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.